These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27468241)

  • 21. Clinical development of an advanced intranasal delivery system of azelastine hydrochloride and fluticasone propionate.
    Derendorf H; Meltzer EO; Hermann R; Canonica GW
    Drugs Today (Barc); 2014 Jan; 50(1):15-31. PubMed ID: 24524103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu.
    Dollner R; Lorentz Larsen P; Dheyauldeen S; Steinsvåg S
    Allergy Rhinol (Providence); 2017 Oct; 8(3):148-156. PubMed ID: 29070272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis.
    Klimek L; Mullol J; Hellings P; Gevaert P; Mösges R; Fokkens W
    Expert Opin Pharmacother; 2016; 17(5):657-69. PubMed ID: 26800187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu
    Marth K; Renner A; Langmayr G; Pohl W; Nguyen DT; Kuhl HC
    Drugs Real World Outcomes; 2024 Jun; 11(2):231-240. PubMed ID: 38351402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps.
    Bousquet J; Bachert C; Bernstein J; Canonica GW; Carr W; Dahl R; Demoly P; Devillier P; Hellings P; Fokkens W; Klimek L; Lieberman P; Meltzer E; Price D; Ryan D; Wahn U
    Expert Opin Pharmacother; 2015 Apr; 16(6):913-28. PubMed ID: 25747125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma.
    Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
    Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
    Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu.
    Klimek L; Demoly P; Price D
    Expert Rev Clin Pharmacol; 2016; 9(5):705-14. PubMed ID: 26839083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study.
    Klimek L; Price D; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J
    Int Arch Allergy Immunol; 2020; 181(10):754-764. PubMed ID: 32829329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.
    Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD
    Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418
    [No Abstract]   [Full Text] [Related]  

  • 31. Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management.
    Bachert C; Bousquet J; Hellings P
    Clin Transl Allergy; 2018; 8():25. PubMed ID: 29983907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers.
    Qi W; Liu Y; Xue W; Li K; Gorski JC; Liu M; Yan T; Nguyen DT; Ramalingam RK
    J Asthma Allergy; 2023; 16():667-677. PubMed ID: 37409000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of MP-AzeFlu enhanced by activation of bitter taste receptor TAS2R.
    Ekstedt S; Kumlien Georén S; Cardell LO
    Allergy Asthma Clin Immunol; 2020; 16():45. PubMed ID: 32514276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Escaping the trap of allergic rhinitis.
    Rossi O; Massaro I; Caminati M; Quecchia C; Fassio F; Heffler E; Canonica GW
    Clin Mol Allergy; 2015; 13(1):17. PubMed ID: 26244040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option.
    Bjermer L; Westman M; Holmström M; Wickman MC
    Allergy Asthma Clin Immunol; 2019; 15():24. PubMed ID: 31015846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care.
    De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB
    World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
    Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis.
    van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J
    J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis.
    Ratner PH; van Bavel JH; Martin BG; Hampel FC; Howland WC; Rogenes PR; Westlund RE; Bowers BW; Cook CK
    J Fam Pract; 1998 Aug; 47(2):118-25. PubMed ID: 9722799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.
    Carr W; Bernstein J; Lieberman P; Meltzer E; Bachert C; Price D; Munzel U; Bousquet J
    J Allergy Clin Immunol; 2012 May; 129(5):1282-1289.e10. PubMed ID: 22418065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.